Re: Potent <i>in vitro</i> activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author's response

Le Terrier, Christophe; Nordmann, Patrice; Poirel, Laurent

doi:10.1016/j.cmi.2024.12.012

Scientific article

Letter

English

Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author's response

ContributorsLe Terrier, Christophe; Nordmann, Patrice; Poirel, Laurent

Published inClinical microbiology and infection, vol. 31, no. 4, p. 662-663

Publication date2025-04

First online date2024-12-21

Abstract

Authors' reply to : Veeraraghavan B, Walia K, Egli A. Re: 'Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates' by Poirel et al. Clin Microbiol Infect. 2025 Apr;31(4):660-661. doi: 10.1016/j.cmi.2024.12.010. Epub 2024 Dec 12. PMID: 39672465, which was a comment on : Le Terrier C, Nordmann P, Delaval A, Poirel L; NARA Network. Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates. Clin Microbiol Infect. 2025 Jan;31(1):122-124. doi: 10.1016/j.cmi.2024.10.012. Epub 2024 Oct 22. PMID: 39447746. https://archive-ouverte.unige.ch/unige:181921

Keywords

Avibactam
Aztreonam
Class B
Durlobactam
E. coli NDM
Metallo-β-lactamase
Sulbactam
Β-lactamase

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences

Research groups

Groupe Pugin Jérôme (Soins intensifs) (587)

Citation (ISO format)

LE TERRIER, Christophe, NORDMANN, Patrice, POIREL, Laurent. Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author’s response. In: Clinical microbiology and infection, 2025, vol. 31, n° 4, p. 662–663. doi: 10.1016/j.cmi.2024.12.012

Article (Published version)

Identifiers

PID : unige:184141
DOI : 10.1016/j.cmi.2024.12.012
PMID : 39716555

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1198743X24005986

Journal ISSN1198-743X

29views

0downloads

Creation17/03/2025 05:11:49

First validation27/03/2025 14:40:45

Update27/03/2025 14:40:45

Status update27/03/2025 14:40:45

Last indexation27/03/2025 14:40:46

Archive ouverte UNIGE

Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author's response

Technical informations